Targeting the IL-6 dependent phenotype can identify novel therapies for cholangiocarcinoma
about
Chemical Library Screening and Structure-Function Relationship Studies Identify Bisacodyl as a Potent and Selective Cytotoxic Agent Towards Quiescent Human Glioblastoma Tumor Stem-Like CellsTumour cell-derived extracellular vesicles interact with mesenchymal stem cells to modulate the microenvironment and enhance cholangiocarcinoma growthA combination of serum leucine-rich α-2-glycoprotein 1, CA19-9 and interleukin-6 differentiate biliary tract cancer from benign biliary strictures.Liver carcinogenesis: rodent models of hepatocarcinoma and cholangiocarcinoma.New insights into the molecular pathogenesis of intrahepatic cholangiocarcinomaHydrodynamic transfection for generation of novel mouse models for liver cancer research.TG2 and NF-κB Signaling Coordinates the Survival of Mantle Cell Lymphoma Cells via IL6-Mediated AutophagyCharacterisation of the immune-related transcriptome in resected biliary tract cancers.MIR21 drives resistance to Heat Shock Protein 90 inhibition in cholangiocarcinoma.Clinical Significance of Soluble Intercellular Adhesion Molecule-1 and Interleukin-6 in Patients with Extrahepatic Cholangiocarcinoma.Gankyrin promotes tumor growth and metastasis through activation of IL-6/STAT3 signaling in human cholangiocarcinoma.Suppression of IL-6 Gene by shRNA Augments Gemcitabine Chemosensitization in Pancreatic Adenocarcinoma Cells.Translational Bioinformatics for Cholangiocarcinoma: Opportunities and Challenges.
P2860
Q28547244-4CFB281E-A2C6-420D-8F61-FD3C7CBD0A2EQ34811043-58F4C8DB-D602-46C6-A1FC-84B91830D84EQ35620650-4003D0A2-F523-45FC-B914-51C113A35A66Q37028411-AE06CEC9-C68F-4DAF-B95E-14ACCBB5BFF8Q37621790-E93C9A53-48B2-411C-89DA-BAED78490358Q38183539-FC5F8138-8C4D-4309-A13D-6B5B099A291EQ38734433-68CE6B98-3BB1-4757-8DF3-DAFBB6A7C9B5Q46243039-4692219C-8388-4489-837F-B216B36156BAQ47429093-211F4EA3-D004-404D-9CFD-2B424C49BD2EQ50025185-88B2266B-FADF-439C-8A69-C61BA7B6B219Q53090136-B1BA6C51-F6E6-4F73-8A0A-B51B8FD3D3C4Q55021190-79E064C4-B9E6-4E70-AEDF-937B097CA39CQ55513254-A748AE6A-CCB4-4E09-B8ED-05427B029250
P2860
Targeting the IL-6 dependent phenotype can identify novel therapies for cholangiocarcinoma
description
2010 nî lūn-bûn
@nan
2010 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Targeting the IL-6 dependent p ...... erapies for cholangiocarcinoma
@ast
Targeting the IL-6 dependent p ...... erapies for cholangiocarcinoma
@en
Targeting the IL-6 dependent p ...... erapies for cholangiocarcinoma
@nl
type
label
Targeting the IL-6 dependent p ...... erapies for cholangiocarcinoma
@ast
Targeting the IL-6 dependent p ...... erapies for cholangiocarcinoma
@en
Targeting the IL-6 dependent p ...... erapies for cholangiocarcinoma
@nl
prefLabel
Targeting the IL-6 dependent p ...... erapies for cholangiocarcinoma
@ast
Targeting the IL-6 dependent p ...... erapies for cholangiocarcinoma
@en
Targeting the IL-6 dependent p ...... erapies for cholangiocarcinoma
@nl
P2093
P2860
P1433
P1476
Targeting the IL-6 dependent p ...... erapies for cholangiocarcinoma
@en
P2093
Chiara Braconi
Erica Swenson
Nianyuan Huang
Takayuki Kogure
Tushar Patel
P2860
P304
P356
10.1371/JOURNAL.PONE.0015195
P407
P577
2010-12-16T00:00:00Z